Average Co-Inventor Count = 7.03
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Immatics Biotechnologies Gmbh (75 from 725 patents)
76 patents:
1. 12297252 - T cell receptors with improved pairing
2. 12060400 - Peptides for use in immunotherapy against cancers
3. 11969464 - Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers
4. 11951132 - Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
5. 11918607 - Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
6. 11904003 - Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers
7. 11833195 - Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers
8. 11801264 - Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
9. 11779606 - Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
10. 11685769 - Peptides for use in immunotherapy against cancers
11. 11376281 - Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
12. 11369636 - Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
13. 11357797 - Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
14. 11214604 - Peptides for use in immunotherapy against cancers
15. 11208449 - Peptides for use in immunotherapy against cancers